Ketamine Inj Per recalls
The FDA has published 1 recall involving Ketamine Inj Per since 2025. The latest was reported on 8 Jan 2025. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2025
Last 12 months0reported
Class I00% of total
Ongoing0latest 8 Jan 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why ketamine inj per is recalled
Companies
By year
All ketamine inj per recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | ketamine inj 50 mg recalled by Hikma Injectables USA | Hikma Injectables USA | Sterility | Nationwide |
Should you stop taking Ketamine Inj Per?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.